X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9640) 9640
Book Review (1595) 1595
Publication (549) 549
Book / eBook (95) 95
Newsletter (58) 58
Book Chapter (31) 31
Conference Proceeding (9) 9
Dissertation (9) 9
Magazine Article (6) 6
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8717) 8717
humans (6298) 6298
male (4193) 4193
animals (4185) 4185
female (4087) 4087
oncology (3251) 3251
cancer (2739) 2739
middle aged (2541) 2541
carcinoma, squamous cell - chemically induced (2425) 2425
aged (2130) 2130
mice (2086) 2086
adult (1755) 1755
carcinoma, squamous cell - pathology (1696) 1696
carcinoma, squamous cell - drug therapy (1244) 1244
rats (1199) 1199
squamous cell carcinoma (1191) 1191
squamous-cell carcinoma (1189) 1189
tumors (1172) 1172
carcinoma (1137) 1137
skin neoplasms - chemically induced (972) 972
expression (952) 952
research (908) 908
chemotherapy (900) 900
apoptosis (890) 890
cell line, tumor (811) 811
carcinogenesis (803) 803
care and treatment (763) 763
carcinogens (721) 721
analysis (719) 719
lung neoplasms - drug therapy (704) 704
metastasis (674) 674
antineoplastic combined chemotherapy protocols - therapeutic use (666) 666
biochemistry & molecular biology (636) 636
cell biology (631) 631
pharmacology & pharmacy (629) 629
gene expression (623) 623
antineoplastic combined chemotherapy protocols - adverse effects (616) 616
abridged index medicus (613) 613
health aspects (610) 610
risk factors (606) 606
neoplasms, experimental - chemically induced (575) 575
proteins (571) 571
antineoplastic agents - adverse effects (560) 560
development and progression (560) 560
time factors (560) 560
skin neoplasms - pathology (559) 559
treatment outcome (558) 558
carcinoma, squamous cell - genetics (551) 551
lung neoplasms - pathology (546) 546
genetic aspects (541) 541
cricetinae (532) 532
aged, 80 and over (529) 529
carcinoma, squamous cell - metabolism (525) 525
immunohistochemistry (525) 525
antineoplastic agents - therapeutic use (506) 506
dose-response relationship, drug (500) 500
cisplatin - administration & dosage (488) 488
disease models, animal (486) 486
article (478) 478
cell proliferation (475) 475
papilloma - chemically induced (474) 474
pathology (473) 473
lung neoplasms - chemically induced (469) 469
lung cancer (466) 466
mouth neoplasms - chemically induced (466) 466
prognosis (466) 466
carcinoma, non-small-cell lung - drug therapy (465) 465
gene expression regulation, neoplastic (465) 465
breast-cancer (450) 450
dermatology (447) 447
cisplatin (437) 437
therapy (430) 430
neoplasm staging (423) 423
medicine & public health (411) 411
toxicology (401) 401
adenocarcinoma - chemically induced (394) 394
9,10-dimethyl-1,2-benzanthracene (388) 388
carcinogens - toxicity (388) 388
mutation (384) 384
research article (382) 382
signal transduction (382) 382
skin (380) 380
cisplatin - adverse effects (372) 372
surgery (372) 372
neutropenia - chemically induced (367) 367
medicine (361) 361
head and neck neoplasms - drug therapy (359) 359
dentistry (354) 354
rodents (353) 353
disease progression (351) 351
mouth neoplasms - pathology (348) 348
skin cancer (344) 344
medicine, research & experimental (341) 341
drug administration schedule (340) 340
cells (334) 334
growth (331) 331
neoplasms - drug therapy (331) 331
cancer research (322) 322
cancer therapies (321) 321
cell cycle (315) 315
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (76) 76
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Online Resources - Online (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Gerstein Science - Reference (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
St. Michael's Hospital - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Gerstein Science - Circulation Desk (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Mt Sinai Hospital - Pathology (1) 1
New College (Ivey) - Stacks (1) 1
Physics - Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
St Josephs Health Centre - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9186) 9186
Japanese (199) 199
German (139) 139
French (92) 92
Chinese (79) 79
Russian (53) 53
Spanish (24) 24
Italian (13) 13
Polish (11) 11
Portuguese (7) 7
Danish (6) 6
Hungarian (2) 2
Norwegian (2) 2
Arabic (1) 1
Croatian (1) 1
Dutch (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 11/2011, Volume 51, Issue 9, pp. 1717 - 1726
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2012, Volume 30, Issue 3, pp. 316 - 321
Journal Article
Journal Article
Nature Cell Biology, ISSN 1465-7392, 01/2014, Volume 16, Issue 10, pp. 982 - 991
Journal Article
Nature, ISSN 0028-0836, 05/2010, Volume 465, Issue 7296, pp. 368 - 372
Calcineurin inhibitors such as cyclosporin A (CsA) are the mainstay of immunosuppressive treatment for organ transplant recipients. Squamous cell carcinoma... 
STEM-CELLS | INHIBITOR DSCR1 | TUMOR SUPPRESSION | MULTIDISCIPLINARY SCIENCES | GROWTH | TRANSFORMED PHENOTYPE | C-MYC | PROLIFERATION | DIFFERENTIATION | CELLULAR SENESCENCE | CARCINOMA | Neoplasm Transplantation | Cell Proliferation | Cyclosporine - pharmacology | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Carcinoma, Squamous Cell - chemically induced | Gene Expression Regulation, Neoplastic | Gene Knockdown Techniques | Calcineurin Inhibitors | Calcineurin - genetics | Cell Transformation, Neoplastic - genetics | Cellular Senescence | Skin Neoplasms - pathology | Signal Transduction | NFATC Transcription Factors - metabolism | Cells, Cultured | Tumor Suppressor Protein p53 - metabolism | Skin Neoplasms - chemically induced | Mice, SCID | Activating Transcription Factor 3 - metabolism | Cell Transformation, Neoplastic - metabolism | Skin Neoplasms - metabolism | Keratinocytes - pathology | Animals | Calcineurin - deficiency | Keratinocytes - metabolism | Cell Line, Tumor | Mice, Inbred NOD | Mice | NFATC Transcription Factors - deficiency | NFATC Transcription Factors - antagonists & inhibitors | Calcineurin - metabolism | NFATC Transcription Factors - genetics | Squamous cell carcinoma | Transcription factors | Calcineurin | Physiological aspects | Diagnosis | Research | Risk factors | Mutation | Cysts | Genes | Binding sites | Cancer | Index Medicus
Journal Article
Oncotarget, ISSN 1949-2553, 2014, Volume 5, Issue 18, pp. 8716 - 8728
The aim of this study was to assess the significance of myeloid-derived suppressor cells (MDSCs) and their association with IL-6 in esophageal squamous cell... 
Esophageal SCC | IL-6 | MDSC | Index Medicus
Journal Article
Nature Communications, ISSN 2041-1723, 2016, Volume 7, Issue 1, pp. 12493 - 12493
Melanoma patients treated with oncogenic BRAF inhibitors can develop cutaneous squamous cell carcinoma (cSCC) within weeks of treatment, driven by paradoxical... 
ACTIVATION | ORIGIN | PROTEIN | MULTIDISCIPLINARY SCIENCES | GROWTH | MUTATIONAL LANDSCAPE | RAF INHIBITORS | MAPK PATHWAY | CANCER | BINDING | SKIN TUMORS | Receptor, Transforming Growth Factor-beta Type I | Receptors, Transforming Growth Factor beta - genetics | Proto-Oncogene Proteins p21(ras) - genetics | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Carcinoma, Squamous Cell - chemically induced | Male | Neoplasms, Experimental - chemically induced | DNA Mutational Analysis - methods | Tumor Suppressor Protein p53 - genetics | Neoplasms, Experimental - pathology | Stem Cells | Receptor, Transforming Growth Factor-beta Type II | Antineoplastic Agents - adverse effects | Neoplasms, Experimental - genetics | Female | Proto-Oncogene Proteins B-raf - metabolism | Proto-Oncogene Proteins p21(ras) - metabolism | Skin Neoplasms - pathology | Carcinogenesis - genetics | Protein-Serine-Threonine Kinases - genetics | Skin Neoplasms - chemically induced | Mice, Inbred Strains | Whole Exome Sequencing | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Vemurafenib | Animals | Indoles - adverse effects | Signal Transduction - drug effects | Biopsy | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Skin Neoplasms - genetics | Cell Line, Tumor | Sulfonamides - adverse effects | Mice | Mutation | Transforming Growth Factor beta - metabolism | Index Medicus | Cell and Molecular Biology | Basic Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Cell- och molekylärbiologi | Medicinska och farmaceutiska grundvetenskaper
Journal Article